These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 25438279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 7. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D, Siegel BA, McDonald DJ, Nussenbaum B.
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J, Fernandez I, Del Hoyo O, Dolado A, Gómez-Suarez J, Hortelano E, Sancho A, Pijoan JI, Alvarez J, Espinosa JM, Gaafar A, Bilbao P.
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [Abstract] [Full Text] [Related]

  • 11. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A.
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [Abstract] [Full Text] [Related]

  • 12. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [Abstract] [Full Text] [Related]

  • 13. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
    Escott EJ.
    Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
    Gourin CG, Watts T, Williams HT, Patel VS, Bilodeau PA, Coleman TA.
    Laryngoscope; 2009 Apr; 119(4):703-6. PubMed ID: 19205017
    [Abstract] [Full Text] [Related]

  • 18. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
    Evangelista L, Cervino AR, Chondrogiannis S, Marzola MC, Maffione AM, Colletti PM, Muzzio PC, Rubello D.
    Nucl Med Commun; 2014 Feb; 35(2):123-34. PubMed ID: 24220055
    [Abstract] [Full Text] [Related]

  • 19. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
    Huang YT, Ravi Kumar AS.
    Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
    [Abstract] [Full Text] [Related]

  • 20. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer.
    Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY.
    World J Gastroenterol; 2015 Mar 14; 21(10):2988-96. PubMed ID: 25780297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.